Quantitative analyses of schizophrenia-associated metabolites in serum: Serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Fukushima, Takeshi ^a   Iizuka, Hideaki ^a   Yokota, Ayaka ^a   Suzuki, Takehiro ^a   Ohno, Chihiro ^a   Kono, Yumiko ^a   Nishikiori, Minami ^a   Seki, Ayaka ^a   Ichiba, Hideaki ^a   Watanabe, Yoshinori ^b   Hongo, Seiji ^b   Utsunomiya, Mamoru ^c   Nakatani, Masaki ^c   Sadamoto, Kiyomi ^d   Yoshio, Takashi ^a  

^a TOHO UNIVERSITY   (Japan)

^b Nanko Clinic of Psychiatry Himorogi Group Medical Corporation JISENKAI   (Japan)

^c Public Interest Incorporated Foundation Sumiyoshi kaiseikai Sumiyoshi Hospital   (Japan)

^d YOKOHAMA COLLEGE OF PHARMACY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALANINE; ARACHIDONIC ACID; ARGININE; ASPARAGINE; CYSTEINYLGLYCINE; DEXTRO LACTIC ACID; DEXTRO SERINE; GAMMA GLUTAMYLCYSTEINE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCINE; HISTIDINE; ISOLEUCINE; KYNURENINE; LACTIC ACID DERIVATIVE; LEUCINE; LINOLEIC ACID; LYSINE; METHYLGLYOXAL; PHENYLALANINE; PROLINE; SERINE; SEROTONIN; THREONINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINE; DIPEPTIDE; GAMMA-GLUTAMYLCYSTEINE;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEXTRO LACTATE BLOOD LEVEL; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; MALE; OXIDATIVE STRESS; PARTIAL LEAST SQUARES REGRESSION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BLOOD; CASE CONTROL STUDY; METABOLISM; METABOLOME; METABOLOMICS; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DIPEPTIDES; FEMALE; GLUTATHIONE; HUMANS; LACTATES; MALE; METABOLOME; METABOLOMICS; ROC CURVE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84903955216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101652     Document Type: Article

References (46)

1. Freedman R (2003) Schizophrenia. N Engl J Med 349: 1738-1749.
2. Yang J, Chen T, Sun L, Zhao Z, Qi X, et al. (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18: 67-78.
3. Cai H-L, Li H-D, Yan X-Z, Sun B, Zhang Q, et al. (2012) Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res 11: 4338-4350.
4. Xuan J, Pan G, Qiu Y, Yang L, Su M, et al. (2011) Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res 10: 5433-5443.
5. Schell M, Brady R, Molliver M, Snyder S (1997) D-Serine as a neuromodulator: Regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci 17: 1604-1615. (Pubitemid 27089806)
6. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, et al. (2003) Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60: 572-576. (Pubitemid 36682314)
7. Hashimoto K, Shimizu E, Iyo M (2005) Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr Psychiatry Rev 1: 151-163.
8. Bitanihirwe BKY, Woo T-UW (2011) Oxidative stress in schizophrenia: An integrated approach. Neurosci Biobehav Rev 35: 878-893.
9. Raffa M, Mechri A, Ben Othman L, Fendri C, Gaha L, et al. (2009) Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuro-Psychopharmacol Biol Psychiatry 33: 1178-1183.
10. Calcia Marilia A, Madeira C, Alheira Flavio V, Silva Thuany CS, Tannos Filippe M, et al. (2012) Plasma levels of D-serine in Brazilian individuals with schizophrenia. Schizophr Res 142: 83-87.
11. Tomiya M, Fukushima T, Kawai J, Aoyama C, Mitsuhashi S, et al. (2006) Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine. Biomed Chromatogr 20: 628-633. (Pubitemid 44043408)
12. Tomiya M, Fukushima T, Watanabe H, Fukami G, Fujisaki M, et al. (2007) Alterations in serum amino acid concentrations in male and female schizophrenic patients. Clin Chim Acta 380: 186-190. (Pubitemid 46505332)
13. Aoyama C, Santa T, Tsunoda M, Fukushima T, Kitada C, et al. (2004) A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent. Biomed Chromatogr 18: 630-636. (Pubitemid 39591834)
14. Isokawa M, Funatsu T, Tsunoda M (2013) Fast and simultaneous analysis of biothiols by high-performance liquid chromatography with fluorescence detection under hydrophilic interaction chromatography conditions. Analyst (Cambridge, U K) 138: 3802-3808.
15. Fukushima T, Kawai J, Imai K, Toyo'oka T (2004) Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed Chromatogr 18: 813-819. (Pubitemid 40089852)
16. Hasegawa H, Fukushima T, Lee J-A, Tsukamoto K, Moriya K, et al. (2003) Determination of serum D-lactic and L-lactic acids in normal subjects and diabetic patients by column-switching HPLC with pre-column fluorescence derivatization. Anal Bioanal Chem 377: 886-891. (Pubitemid 40877854)
17. Tsai Y, Liao T, Lee J (2003) Identification of L-3-hydroxybutyrate as an original ketone body in rat serum by column-switching high-performance liquid chromatography and fluorescence derivatization. Anal Biochem 319: 34-41. (Pubitemid 36802140)
18. Hsu WY, Kuo CY, Fukushima T, Imai K, Chen CM, et al. (2011) Enantioselective determination of 3-hydroxybutyrate in the tissues of normal and streptozotocin-induced diabetic rats of different ages. J Chromatogr B 879: 3331-3336.
19. Prados P, Fukushima T, Santa T, Homma H, Tsunoda M, et al. (1997) 4-N,N-Dimethylaminosulfonyl-7-N-(2-aminoethyl)amino-benzofurazan as a new precolumn fluorescence derivatization reagent for carboxylic acids (fatty acids and drugs containing a carboxyl moiety) in liquid chromatography. Anal Chim Acta 344: 227-232. (Pubitemid 27264354)
20. Fukushima T, Mitsuhashi S, Tomiya M, Iyo M, Hashimoto K, et al. (2007) Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids. Clin Chim Acta 377: 174-178. (Pubitemid 44914069)
21. Mitsuhashi S, Fukushima T, Kawai J, Tomiya M, Santa T, et al. (2006) Improved method for the determination of kynurenic acid in rat plasma by column-switching HPLC with post-column fluorescence detection. Anal Chim Acta 562: 36-43. (Pubitemid 43339970)
22. Ohashi H, Iizuka H, Yoshihara S, Otani H, Kume M, et al. (2013) Determination of l-tryptophan and l-kynurenine in human serum by using LC-MS after derivatization with (R)-DBD-PyNCS. Int J Tryptophan Res 6: 9-14.
23. Hubbard KE, Wells A, Owens TS, Tagen M, Fraga CH, et al. (2010) Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection. Biomed Chromatogr 24: 626-631.
24. Yao JK, Keshavan MS (2011) Antioxidants, redox signaling, and pathophysiology in schizophrenia: An integrative view. Antioxid Redox Signaling 15: 2011-2035.
25. Thornalley PJ (1994) Methylglyoxal, glyoxalases and the development of diabetic complications. Amino Acids 6: 15-23.
26. Kalapos M (1999) Methylglyoxal in living organisms - Chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 110: 145-175.
27. Arai M, Yuzawa H, Nohara I, Ohnishi T, Obata N, et al. (2010) Enchanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry 67: 589-597.
28. Gysin R (2007) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci U S A 104: 16621-16626.
29. Nichenarnetla SN, Ellison I, Calcagnotto A, Lazarus P, Muscat JE, et al. (2008) Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase. Free Radical Biol Med 45: 645-650.
30. Gawryluk JW, Wang J-F, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14: 123-130.
31. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, et al. (2013) Suppression of oxidative stress by b-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (Washington, DC, U S) 339: 211-214.
32. Ramos-Loyo J, Medina-Hernandez V, Estarron-Espinosa M, Canales-Aguirre A, Gomez-Pinedo U, et al. (2013) Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 44: 154-161.
33. Maekawa M, Owada Y, Yoshikawa T (2011) Role of polyunsaturated fatty acids and fatty acid binding protein in the pathogenesis of schizophrenia. Curr Pharm Des 17: 168-175.
34. Iwayama Y, Hattori E, Maekawa M, Yamada K, Toyota T, et al. (2010) Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder. Am J Med Genet, Part B 153B: 484-493.
35. Myint AM (2012) Kynurenines: from the perspective of major psychiatric disorders. FEBS J 279: 1375-1385.
36. Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, et al. (2010) Altered interactions of tryptophan metabolites in first-episode neurolepticnaive patients with schizophrenia. Mol Psychiatry 15: 938-953.
37. Moroni F (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375: 87-100.
38. Batabyal D, Yeh S-R (2007) Human tryptophan dioxygenase: A comparison to indoleamine 2,3-dioxygenase. J Am Chem Soc 129: 15690-15701.
39. Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, et al. (2008) Biogenic amines in the reduction of oxidative stress: Melatonin and its metabolites. Neuroendocrinol Lett 29: 391-398.
40. Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, et al. (2001) Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50: 521-530. (Pubitemid 32971883)
41. Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom LH, et al. (2001) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313: 96-98. (Pubitemid 32973903)
42. Schell M, Molliver M, Snyder S (1995) D-Serine, an endogenous synaptic modulator - localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92: 3948-3952.
43. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99: 13675-13680. (Pubitemid 35215440)
44. Madeira C, Freitas ME, Vargas-Lopes C, Wolosker H, Panizzutti R (2008) Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res 101: 76-83.
45. Miljevic C, Nikolic-Kokic A, Nikolic M, Niketic V, Spasic MB, et al. (2013) Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study). Hum Psychopharmacol Clin Exp 28: 1-6.
46. Tortorella A, Monteleone P, Fabrazzo M, Viggiano A, De Luca L, et al. (2001) Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiol 44: 167-171. (Pubitemid 33036026)